Why do we need to talk more about CBG?

Cannabigerol (CBG) is a phytocannabinoid with distinct and promising therapeutic properties. Less known than tetrahydrocannabinol (THC) and cannabidiol (CBD), CBG offers unique advantages due to its interaction with the endocannabinoid system and other biological systems.

To start discussing the "parent" of cannabinoids, we need to highlight actions that enhance its therapeutic benefits. CBG inhibits the uptake of gamma-aminobutyric acid (GABA) more effectively than THC or CBD. GABA is a crucial inhibitory neurotransmitter in the brain, helping to regulate neuronal excitability. This suggests that CBG may be more effective than CBD and THC in treating anxiety, muscle spasms, and chronic pain.
 

Analgesic and anti-inflammatory properties

CBG exhibits analgesic and anti-inflammatory properties, similar to those of CBD. It may accelerate the healing process and help with inflammatory conditions and chronic pain. Studies suggest that CBG may reduce intraocular pressure, benefiting patients with glaucoma. Additionally, CBG has shown potential in treating inflammatory skin diseases, such as psoriasis.

Interactions with receptors

CBG interacts with the TRPV2 receptor, helping to reduce pain and regulate glucose levels, which may be useful in treating diabetes. It also blocks the TRPV8 receptor, decreasing sensitivity to cold and inflammation. These properties are valuable for conditions such as arthritis and chronic inflammatory diseases.

Treatment of epilepsy

CBG acid (CBGA), the acidic form of CBG, has proven to be more effective than CBD in treating epilepsy in animal models. This opens new possibilities for more effective treatments for difficult-to-control types of epilepsy.

Neuroprotection and neurodegenerative diseases

CBG is being studied as a potential treatment for neurodegenerative diseases, such as Huntington's disease, Parkinson's disease, and multiple sclerosis. Its neuroprotective properties are believed to be linked to its interaction with the PPARγ receptor, which is important in regulating inflammation and lipid metabolism.

Gastrointestinal benefits

CBG may help treat inflammatory bowel conditions, such as colitis and Crohn's disease, and increase appetite in patients suffering from weight loss associated with chemotherapy. Although the results regarding the impact on appetite are still inconclusive, CBG offers a non-psychoactive alternative to THC for these patients.

Clinical studies

The most significant study on CBG was conducted by Washington State University and UCLA, demonstrating that CBG can reduce anxiety and improve verbal memory in humans. These results are promising, but more research is needed to confirm the safety and efficacy of CBG.

CBG presents significant therapeutic potential, but research is in its early stages. It is essential to use CBG products under professional guidance to avoid possible contraindications and drug interactions. The future of CBG in medicine may bring new treatment opportunities, with more studies promising to expand its therapeutic use.